The Significance of Serum HBV Pregenomic RNA in Patients with Low HBsAg Chronic Hepatitis B Following Peg-Interferon Alfa Therapy

被引：0
|
作者：
Wang, Menglan [1 ]
Chen, Youming [1 ]
Lin, Bingliang [1 ]
Xie, Dongying [1 ]
Deng, Hong [1 ]
Lin, Chaoshuang [1 ]
Xie, Qifeng [1 ]
Zhang, Xiaohong [1 ]
Gao, Zhiliang [1 ]
机构：
[1] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
557
引用
收藏
页码：333A / 333A
页数：1
相关论文
共 50 条
  • [31] CHRONIC PAIN IN HEPATITIS PATIENTS PRE AND POST PEG-INTERFERON TREATMENT
    Lallemant, Camille
    Greenwood, Matthew
    Muir, Jane
    Keller, Majella
    Tibble, Jerry
    Whale, Richard
    Haq, Inam
    [J]. RHEUMATOLOGY, 2010, 49 : I62 - I62
  • [32] Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss
    Wu, I-Chin
    Liu, Wen-Chun
    Chiu, Yen-Cheng
    Chiu, Hung-Chih
    Cheng, Pin-Nan
    Chang, Ting-Tsung
    [J]. MICROORGANISMS, 2021, 9 (06)
  • [33] In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection
    Sprengers, D.
    van der Molen, R. G.
    Binda, R.
    Kusters, J. G.
    de Man, R. A.
    Niesters, H. G. M.
    Schalm, S. W.
    Janssen, H. L. A.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 743 - 749
  • [34] Increase of Serum Ferritin as a Marker for the rRVR under antiviral Triple Therapy with Telaprevir, PEG-Interferon alfa-2a and Ribavirin for chronic Hepatitis C
    Zopf, S.
    Janisch, F.
    Siebler, J.
    Neurath, M.
    Janisch, H.
    [J]. INTERNIST, 2013, 54 : 29 - 29
  • [35] Treatment and outcome of genotype 4 chronic hepatitis C patients with Peg-interferon alfa 2b and ribavirin in the clinical setting in Germany
    Zehnter, E.
    Hueppe, D.
    Manns, M. P.
    Mauss, S.
    Zankel, M.
    [J]. LIVER INTERNATIONAL, 2006, 26 : 77 - 77
  • [36] Danazol in the treatment of thrombocytopenia associated with the use of peg-interferon alfa 2a and Ribavirin in patients with chronic hepatitis C
    Gomez-Galicia, Diana
    Cabrera-Alvarez, Guillermo
    Rodriguez-Fragoso, Lourdes
    Reyes-Esparza, Jorge
    [J]. FASEB JOURNAL, 2010, 24
  • [37] Treatment of chronic hepatitis delta with PEG-interferon alpha-2b.
    Castelnau, C
    Gordien, E
    Boyer, N
    Martinot, M
    Deny, P
    Marcellin, P
    [J]. HEPATOLOGY, 2004, 40 (04) : 675A - 675A
  • [38] Comparison of low dose with standard dose PEG-interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C.
    Krawitt, EL
    Grace, ND
    Gordon, SR
    Fromm, H
    Palmer, M
    Yarze, JC
    Sheinbaum, A
    Thomson, RD
    Moskowitz, S
    Schapira, L
    Corsanti, JG
    Polio, J
    Smith, RE
    Levine, RA
    Bank, L
    Kilby, AE
    Fried, MB
    Antignano, LV
    Kohagen, KR
    Ferrentino, N
    Lidofsky, SD
    LaBrecque, DR
    [J]. HEPATOLOGY, 2003, 38 (04) : 738A - 738A
  • [39] Use of Quantitative Serum HBsAg for Optimization of Therapy in Chronic Hepatitis B Patients Treated with Pegylated Interferon Alfa-2a: a Romanian Cohort Study
    Gheorghita, Valeriu I.
    Caruntu, Florin Alexandru
    Curescu, Manuela
    Olaru, Ioana
    Radu, Monica Nicoleta
    Coltan, Gabriel
    Streinu-Cercel, Adrian
    [J]. JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2013, 22 (01) : 27 - 32
  • [40] Combination therapy with hepatitis B vaccine and interferon alfa in chronic hepatitis B
    Kaymakoglu, S
    Demir, K
    Çakaloglu, Y
    Tuncer, I
    Dinçer, D
    Gürel, S
    Ökten, A
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (03): : 856 - 857
12345